Your browser doesn't support javascript.
loading
New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk.
Graham, Ian; Shear, Chuck; De Graeff, Pieter; Boulton, Caroline; Catapano, Alberico L; Stough, Wendy Gattis; Carlsson, Stefan C; De Backer, Guy; Emmerich, Joseph; Greenfeder, Scott; Kim, Albert M; Lautsch, Dominik; Nguyen, Tu; Nissen, Steven E; Prasad, Krishna; Ray, Kausik K; Robinson, Jennifer G; Sasiela, William J; Bruins Slot, Karsten; Stroes, Erik; Thuren, Tom; Van der Schueren, Bart; Velkovski-Rouyer, Maja; Wasserman, Scott M; Wiklund, Olov; Zouridakis, Emmanouil.
Affiliation
  • Graham I; Trinity College, Adelaide Health Foundation, Tallaght Hospital, Dublin 24, Ireland.
  • Shear C; Global Product Development/Internal Medicine, Pfizer, Inc., 235 E. 42nd Street, New York, New York 10017, NY, USA.
  • De Graeff P; Dutch Medicines Evaluation Board (CBG-MEB), Graadt Van Roggenweg 500, 3531 AH Utrecht, The Netherlands.
  • Boulton C; Department of Pharmacy and Clinical Pharmacology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
  • Catapano AL; Novartis Pharma AG, Asklepios 8, 4056 Basel, Switzerland.
  • Stough WG; Department of Pharmacological and Biomolecular Sciences and Multimedica IRCCS, University of Milan, via Balzaretti 9, 20133 Milano, Italy.
  • Carlsson SC; Departments of Clinical Research and Pharmacy Practice, Campbell University College of Pharmacy and Health Sciences, 217 Main St., Buies Creek, NC 27506, USA.
  • De Backer G; Cardiovascular Pharmacology, AstraZeneca, Pepparredsleden 1, SE-431 83 Mölndal, Sweden.
  • Emmerich J; Department of Public Health, Faculty of Medicine and Health Sciences, Ghent University, University Hospital, K3, 4th floor, De Pintelaan 185, B9000 Ghent, Belgium.
  • Greenfeder S; Université Paris-Descartes, Cochin-Hôtel Dieu Hospital, French National Agency for Medicines and Health Products Safety, 143/147, Boulevard, Anatole France 93285, Saint-Denis, France.
  • Kim AM; Regulatory Affairs, Daiichi-Sankyo, 211 Mt. Airy Road, Basking Ridge, NJ 07920, USA.
  • Lautsch D; Internal Medicine Research Unit, Pfizer, Inc., 1 Portland St., 4th floor, Cambridge, MA 02139, USA.
  • Nguyen T; Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.
  • Nissen SE; Sanofi, 55 Corporate Drive, Bridgewater, NJ, USA.
  • Prasad K; Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
  • Ray KK; Licensing Division, United Kingdom Medicines and Healthcare Products Regulatory Agency, 151 Buckingham Palace Road, London SW1W 9SZ, UK.
  • Robinson JG; Department of Primary Care and Public Health, Imperial College, 323 Reynolds Building, Room 320, Charing Cross Hospital, London W68RF, UK.
  • Sasiela WJ; Department of Epidemiology, College of Public Health, University of Iowa, 145 N. Riverside Dr S455 CPHB, Iowa City, IA 52242, USA.
  • Bruins Slot K; Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.
  • Stroes E; Oslo University Hospital, Ullevål, Medical Department, Postboks 4956 Nydalen, 0424 Oslo, Norway.
  • Thuren T; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Van der Schueren B; Novartis Pharma AG, Asklepios 8, 4056 Basel, Switzerland.
  • Velkovski-Rouyer M; Laboratory of Experimental Medicine and Endocrinology, University of Leuven, Herestraat 49, 3000 Leuven, Belgium.
  • Wasserman SM; Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.
  • Wiklund O; Amgen, One Amgen Center Drive, MS 38.2.C, Thousand Oaks, CA 91320, USA.
  • Zouridakis E; Wallenberg Laboratory, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.
Eur Heart J Cardiovasc Pharmacother ; 4(2): 119-127, 2018 04 01.
Article in En | MEDLINE | ID: mdl-29194462
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiology / Cardiovascular Diseases / Practice Guidelines as Topic / Drug Development / Lipids / Hypolipidemic Agents Type of study: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur Heart J Cardiovasc Pharmacother Year: 2018 Document type: Article Affiliation country: Ireland Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiology / Cardiovascular Diseases / Practice Guidelines as Topic / Drug Development / Lipids / Hypolipidemic Agents Type of study: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur Heart J Cardiovasc Pharmacother Year: 2018 Document type: Article Affiliation country: Ireland Country of publication: United kingdom